open access

Ahead of Print
Research paper
Published online: 2024-01-05
Get Citation

Clinical use of redox biomarkers for diagnosis of male infertility

Marek Szymanski123, Radoslaw Janicki23, Piotr Kaminski4, Karolina Wasilow3, Jaromir Soltysiak5, Robert Szyca6, Angelika Szymanska7, Marcin Arabik8
·
Pubmed: 38334352
Affiliations
  1. Department of Obstetrics and Gynecology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland, Bydgoszcz
  2. Gynecology, Oncological Gynecology and Gynecological Endocrynology Clinic, 10th Military Research Hospital and Polyclinic, IPHC, Bydgoszcz, Poland
  3. NZOZ Medical Center, Clinic of Infertility Treatment “Genesis”, Bydgoszcz, Poland
  4. Department of Ecology and Environmental Protection, Department of Medical Biology and Biochemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
  5. “Solmed Medical” Center Chojnice, Poland
  6. Clinic of Surgery and Oncological Surgery, 10th Military Research Hospital and Polyclinic, IPHC, Bydgoszcz, Poland.
  7. The National Institute of Medicine of the Ministry of Interior and Administration, Warsaw, Poland
  8. Gynecology, Obstetrics and Pregnancy Pathology Department, Multi-speciality City Hospital in Bydgoszcz, Poland

open access

Ahead of Print
ORIGINAL PAPERS Gynecology
Published online: 2024-01-05

Abstract

The aim of the study was to analyze the activity of antioxidant enzymes (glutathione reductase, catalase, superoxide dismutase) and malondialdehyde (MDA) levels in a population of men with abnormal semen parameters and in a population of men diagnosed with normozoospermia. This study was performed using data collected at the Infertility Treatment Clinic ‚Genesis’ , Bydgoszcz, Poland, between 1 January 2011 and 31 December 2017. A total number of 321 men meeting the inclusion criteria were selected and divided into the control group (162 men) and the infertility group (159 men). The activities of superoxide dismutase (SOD), catalase (CAT), and glutathione reductase (GR) were measured using ready-made kits; lipid peroxidation intensity was determined by the thiobarbituric acid method. No statistically significant differences were found for the activity of SOD, GR, CAT between the groups. MDA values measured in the serum of patients in the healthy group were higher than in the group with semenological disorders. Although our study did not demonstrate the usefulness of the above blood tests, further studies are needed to explore the potential use of assessing redox parameters to develop new diagnostic and therapeutic approaches for male infertility.

Abstract

The aim of the study was to analyze the activity of antioxidant enzymes (glutathione reductase, catalase, superoxide dismutase) and malondialdehyde (MDA) levels in a population of men with abnormal semen parameters and in a population of men diagnosed with normozoospermia. This study was performed using data collected at the Infertility Treatment Clinic ‚Genesis’ , Bydgoszcz, Poland, between 1 January 2011 and 31 December 2017. A total number of 321 men meeting the inclusion criteria were selected and divided into the control group (162 men) and the infertility group (159 men). The activities of superoxide dismutase (SOD), catalase (CAT), and glutathione reductase (GR) were measured using ready-made kits; lipid peroxidation intensity was determined by the thiobarbituric acid method. No statistically significant differences were found for the activity of SOD, GR, CAT between the groups. MDA values measured in the serum of patients in the healthy group were higher than in the group with semenological disorders. Although our study did not demonstrate the usefulness of the above blood tests, further studies are needed to explore the potential use of assessing redox parameters to develop new diagnostic and therapeutic approaches for male infertility.

Get Citation

Keywords

male infertility; oxidative stress; reactive oxygen species; superoxide dismutase; catalase; glutathione reductase; MDA; antioxidant defense

About this article
Title

Clinical use of redox biomarkers for diagnosis of male infertility

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Research paper

Published online

2024-01-05

Page views

232

Article views/downloads

151

DOI

10.5603/gpl.98046

Pubmed

38334352

Keywords

male infertility
oxidative stress
reactive oxygen species
superoxide dismutase
catalase
glutathione reductase
MDA
antioxidant defense

Authors

Marek Szymanski
Radoslaw Janicki
Piotr Kaminski
Karolina Wasilow
Jaromir Soltysiak
Robert Szyca
Angelika Szymanska
Marcin Arabik

References (57)
  1. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010; 16(3): 231–245.
  2. Aitken RJ. Impact of oxidative stress on male and female germ cells: implications for fertility. Reproduction. 2020; 159(4): R189–R201.
  3. Aitken RJ, Drevet JR, Moazamian A, et al. Male infertility and oxidative stress: a focus on the underlying mechanisms. Antioxidants (Basel). 2022; 11(2).
  4. Wagner H, Cheng JW, Ko EY. Role of reactive oxygen species in male infertility: An updated review of literature. Arab J Urol. 2018; 16(1): 35–43.
  5. Lotti F, Maggi M. Sexual dysfunction and male infertility. Nat Rev Urol. 2018; 15(5): 287–307.
  6. Nallella KP, Sharma RK, Aziz N, et al. Significance of sperm characteristics in the evaluation of male infertility. Fertil Steril. 2006; 85(3): 629–634.
  7. Sharlip I, Jarow J, Belker A, et al. Best practice policies for male infertility. Fertil Steril. 2002; 77(5): 873–882.
  8. Mannucci A, Argento FR, Fini E, et al. The impact of oxidative stress in male infertility. Front Mol Biosci. 2021; 8: 799294.
  9. Jungwirth A, Giwercman A, Tournaye H, et al. European Association of Urology guidelines on male infertility: the 2012 update. Eur Urol. 2012; 62(2): 324–332.
  10. Griswold MD. Spermatogenesis: The Commitment to Meiosis. Physiol Rev. 2016; 96(1): 1–17.
  11. Deepinder F, Cocuzza M, Agarwal A. Should seminal oxidative stress measurement be offered routinely to men presenting for infertility evaluation? Endocr Pract. 2008; 14(4): 484–491.
  12. Makker K, Agarwal A, Sharma R. Oxidative stress & male infertility. Indian J Med Res. 2009; 129(4): 357–367.
  13. Sabeti P, Pourmasumi S, Rahiminia T, et al. Etiologies of sperm oxidative stress. Int J Reprod Biomed. 2016; 14(4): 231–240.
  14. Huang C, Cao X, Pang D, et al. Is male infertility associated with increased oxidative stress in seminal plasma? A-meta analysis. Oncotarget. 2018; 9(36): 24494–24513.
  15. Saikolappan S, Kumar B, Shishodia G, et al. Reactive oxygen species and cancer: a complex interaction. Cancer Lett. 2019; 452: 132–143.
  16. Galadari S, Rahman A, Pallichankandy S, et al. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017; 104: 144–164.
  17. Agarwal A, Majzoub A. Laboratory tests for oxidative stress. Indian J Urol. 2017; 33(3): 199–206.
  18. Dutta S, Majzoub A, Agarwal A. Oxidative stress and sperm function: a systematic review on evaluation and management. Arab J Urol. 2019; 17(2): 87–97.
  19. Martins AD, Agarwal A. Oxidation reduction potential: a new biomarker of male infertility. Panminerva Med. 2019; 61(2): 108–117.
  20. Agarwal A, Makker K, Sharma R. Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol. 2008; 59(1): 2–11.
  21. Hosseinzadeh Colagar A, Karimi F, Jorsaraei SG. Correlation of sperm parameters with semen lipid peroxidation and total antioxidants levels in astheno- and oligoasheno- teratospermic men. Iran Red Crescent Med J. 2013; 15(9): 780–785.
  22. Agarwal A, Rana M, Qiu E, et al. Role of oxidative stress, infection and inflammation in male infertility. Andrologia. 2018; 50(11): e13126.
  23. Irato P, Santovito G. Enzymatic and non-enzymatic molecules with antioxidant function. Antioxidants (Basel). 2021; 10(4): 579.
  24. Sharma VK, Singh TG, Garg N, et al. Dysbiosis and Alzheimer's disease: a role for chronic stress? Biomolecules. 2021; 11(5): 678.
  25. Druga twarz tlenu: wolne rodniki w przyrodzie. Wydawnictwo Naukowe PWN, Warszawa 2022.
  26. Bhattacharya T, Dey PS, Akter R, et al. Effect of natural leaf extracts as phytomedicine in curing geriatrics. Exp Gerontol. 2021; 150: 111352.
  27. Kulbacka J, Saczko J, Chwiłkowska A. [Oxidative stress in cells damage processes]. [Article in Polish]. Pol Merkur Lekarski. 2009; 27(157): 44–47.
  28. Arya A, Chahal R, Rao R, et al. Acetylcholinesterase inhibitory potential of various sesquiterpene analogues for alzheimer's disease therapy. Biomolecules. 2021; 11(3): 350.
  29. Rice-Evans C, Diplock AT, Symons MC. Techniques in free radical research. Elsevier, Amsterdam, London, New York, Tokyo 1991.
  30. Atmaca M, Tezcan E, Kuloglu M, et al. Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci. 2004; 254(4): 231–235.
  31. Hill SA. Statistics. In foundations of anesthesia. In: Hemmings HC, Hopkins PM. ed. Foundations of anesthesia. Basic sciences for clinical practice. Elsevier 2006: 207–217.
  32. Tafuri S, Ciani F, Iorio E, et al. Reactive oxygen species (ROS) and male fertility. New Discoveries in Embryology. 2015.
  33. Ayaz A, Agarwal A, Sharma R, et al. Impact of precise modulation of reactive oxygen species levels on spermatozoa proteins in infertile men. Clin Proteomics. 2015; 12(1): 4.
  34. Agarwal A, Roychoudhury S, Bjugstad KB, et al. Oxidation-reduction potential of semen: what is its role in the treatment of male infertility? Ther Adv Urol. 2016; 8(5): 302–318.
  35. Adewoyin M, Ibrahim M, Roszaman R, et al. Male infertility: the effect of natural antioxidants and phytocompounds on seminal oxidative stress. Diseases. 2017; 5(1): 9.
  36. Talevi R, Barbato V, Fiorentino I, et al. Protective effects of in vitro treatment with zinc, d-aspartate and coenzyme q10 on human sperm motility, lipid peroxidation and DNA fragmentation. Reprod Biol Endocrinol. 2013; 11: 81.
  37. Martin-Hidalgo D, Bragado MJ, Batista AR, et al. Antioxidants and male fertility: from molecular studies to clinical evidence. Antioxidants (Basel). 2019; 8(4): 89.
  38. Nowicka-Bauer K, Nixon B. Molecular changes induced by oxidative stress that impair human sperm motility. Antioxidants (Basel). 2020; 9(2): 134.
  39. Li Y, Sun Y, Ni A, et al. Seminal plasma proteome as an indicator of sperm dysfunction and low sperm motility in chickens. Mol Cell Proteomics. 2020; 19(6): 1035–1046.
  40. Rizkallah N, Chambers CG, de Graaf SP, et al. Factors affecting the survival of ram spermatozoa during liquid storage and options for improvement. Animals (Basel). 2022; 12(3): 244.
  41. Su LJ, Zhang JH, Gomez H, et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev. 2019; 2019: 5080843.
  42. Cito G, Becatti M, Natali A, et al. Redox status assessment in infertile patients with non-obstructive azoospermia undergoing testicular sperm extraction: A prospective study. Andrology. 2020; 8(2): 364–371.
  43. Agarwal A, Virk G, Ong C, et al. Effect of oxidative stress on male reproduction. World J Mens Health. 2014; 32(1): 1–17.
  44. Zribi N, Chakroun NF, Elleuch H, et al. Sperm DNA fragmentation and oxidation are independent of malondialdheyde. Reprod Biol Endocrinol. 2011; 9: 47.
  45. Taken K, Ekin S, Arısoy A, et al. Erectile dysfunction is a marker for obstructive sleep apnea. Aging Male. 2016; 19(2): 102–105.
  46. Kasperczyk A, Dobrakowski M, Czuba ZP, et al. Influence of iron on sperm motility and selected oxidative stress parameters in fertile males — a pilot study. Ann Agric Environ Med. 2016; 23(2): 292–296.
  47. Morales M, Munné-Bosch S. Malondialdehyde: facts and artifacts. Plant Physiol. 2019; 180(3): 1246–1250.
  48. Gutiérrez-Salinas J, García-Ortíz L, González JM, et al. In vitro effect of sodium fluoride on malondialdehyde concentration and on superoxide dismutase, catalase, and glutathione peroxidase in human erythrocytes. ScientificWorldJournal. 2013; 2013: 864718.
  49. Naher ZU, Ali M, Biswas SK, et al. Effect of oxidative stress in male infertility. Mymensingh Med J. 2013; 22(1): 136–142.
  50. Li Ke, Shang X, Chen Y. High-performance liquid chromatographic detection of lipid peroxidation in human seminal plasma and its application to male infertility. Clin Chim Acta. 2004; 346(2): 199–203.
  51. Fraczek M, Sanocka D, Kamieniczna M, et al. Proinflammatory cytokines as an intermediate factor enhancing lipid sperm membrane peroxidation in in vitro conditions. J Androl. 2008; 29(1): 85–92.
  52. Ajina T, Sallem A, Haouas Z, et al. Total antioxidant status and lipid peroxidation with and without in vitro zinc supplementation in infertile men. Andrologia. 2016; 49(7): e12703.
  53. Shamsi MB, Venkatesh S, Kumar R, et al. Antioxidant levels in blood and seminal plasma and their impact on sperm parameters in infertile men. Indian J Biochem Biophys. 2010; 47(1): 38–43.
  54. Benedetti S, Tagliamonte MC, Catalani S, et al. Differences in blood and semen oxidative status in fertile and infertile men, and their relationship with sperm quality. Reprod Biomed Online. 2012; 25(3): 300–306.
  55. Gambera L, Stendardi A, Ghelardi C, et al. Effects of antioxidant treatment on seminal parameters in patients undergoing in vitro fertilization. Arch Ital Urol Androl. 2019; 91(3).
  56. Alahmar AT, Calogero AE, Singh R, et al. Coenzyme Q10, oxidative stress, and male infertility: A review. Clin Exp Reprod Med. 2021; 48(2): 97–104.
  57. Wadhwa L, Priyadarshini S, Fauzdar A, et al. Impact of vitamin D supplementation on semen quality in vitamin d-deficient infertile males with oligoasthenozoospermia. J Obstet Gynaecol India. 2020; 70(1): 44–49.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl